US Map / Ohio
State OH

Clinical Trials in Ohio

Ohio is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Ohio and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.

Right now ClinicalMetric tracks 475 actively recruiting studies with Ohio sites out of 475 registered in total. The busiest research areas in Ohio are Ovarian Cancer, Solid Tumor, Advanced Solid Tumor. Leading sponsors running trials in the state include Children's Hospital Medical Center, Cincinnati, The Cleveland Clinic, National Cancer Institute (NCI). By stage, Ohio trials break down as Phase 1 (96), Phase 2 (140), Phase 3 (106), Phase 4 (16).

All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.

Total Trials
475
Recruiting Now
475
← Back to US Map
Top Conditions in Ohio
Ovarian Cancer (9)Solid Tumor (8)Advanced Solid Tumor (8)Heart Failure (7)Colorectal Cancer (7)Prostate Cancer (7)Schizophrenia (7)Acute Myeloid Leukemia (6)Advanced Solid Tumors (6)Chronic Lymphocytic Leukemia (6)Multiple Myeloma (5)Metastatic Castration-resistant Prostate Cancer (5)

Frequently Asked Questions — Clinical Trials in Ohio

How many clinical trials are currently recruiting in Ohio?
ClinicalMetric currently tracks 475 actively recruiting clinical trials with at least one location in Ohio. The total number of registered studies—including active but not currently enrolling trials—is 475. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Ohio?
Ohio hosts clinical trials across a broad range of medical conditions, including Ovarian Cancer, Solid Tumor, Advanced Solid Tumor, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Ohio serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Ohio?
To join a clinical trial in Ohio, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Ohio maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in Ohio

NCT06747117 N/A
Recruiting
A Study of Patients With Lower Extremity Acute Limb Ischemia to Remove Thrombus ...
Condition
Lower Extremity Acute Limb Ischemia
Enrollment
300 pts
Location
United States, Australia, Brazil
Sponsor
Penumbra Inc.
View Trial →
NCT07435740 N/A
Recruiting
Parent-Mediated Telehealth Intervention for Insomnia in Young Autistic Children
Condition
Insomnia
Enrollment
130 pts
Location
United States
Sponsor
The Cleveland Clinic
View Trial →
NCT06192576 N/A
Recruiting
A Real-world Long-term Safety and Immunogenicity Study of Olipudase Alfa Therapy...
Condition
Niemann-Pick Diseases
Enrollment
10 pts
Location
United States
Sponsor
Sanofi
View Trial →
NCT06628908 Phase 3
Recruiting
Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabet...
Condition
Diabetic Peripheral Neuropathic Pain
Enrollment
1,100 pts
Location
United States
Sponsor
Vertex Pharmaceuticals Incorpo
View Trial →
NCT07506525 N/A
Recruiting
Flourish in Schools Pilot Study
Condition
Psychological Distress
Enrollment
20 pts
Location
United States
Sponsor
Candice Biernesser
View Trial →
NCT07293715 Phase 4
Recruiting
Permissive Versus Strict Intrapartum Glucose Management in Type 1 and Type 2 Dia...
Condition
Pregnancy, High Risk
Enrollment
44 pts
Location
United States
Sponsor
Ohio State University
View Trial →
NCT04792489 Phase 2
Recruiting
DALY II USA/ MB-CART2019.1 for DLBCL
Condition
Refractory Diffuse Large B Cell Lymphoma (DLBCL)
Enrollment
315 pts
Location
United States, Canada
Sponsor
Miltenyi Biomedicine GmbH
View Trial →
NCT05475925 Phase 1, Phase 2
Recruiting
A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotox...
Condition
LGLL - Large Granular Lymphocytic Leukemia
Enrollment
200 pts
Location
United States, Australia, France
Sponsor
Dren Bio
View Trial →
NCT06425926 Phase 1, Phase 2
Recruiting
Safety and Tolerability Study of GIM-531 in Advanced Solid Tumors
Condition
Melanoma Stage IV
Enrollment
117 pts
Location
United States
Sponsor
Georgiamune Inc
View Trial →
NCT04614103 Phase 2
Recruiting
Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer
Condition
Metastatic Non Small Cell Lung Cancer
Enrollment
170 pts
Location
United States, Australia, Canada
Sponsor
Iovance Biotherapeutics, Inc.
View Trial →
NCT05919342 N/A
Recruiting
Screening for earlY Heart Failure Diagnosis and Management in Primary Care or at...
Condition
Heart Failure
Enrollment
3,904 pts
Location
United States, Canada, Denmark
Sponsor
NHS Greater Glasgow and Clyde
View Trial →
NCT06965127 N/A
Recruiting
Implant for Walking After Incomplete SCI
Condition
Spinal Cord Injury (SCI)
Enrollment
5 pts
Location
United States
Sponsor
Louis Stokes VA Medical Center
View Trial →
NCT04649242 Phase 3
Recruiting
Randomized Study in Children and Adolescents With Migraine: Acute Treatment
Condition
Pediatric Migraine
Enrollment
2,100 pts
Location
United States, Canada, China
Sponsor
Pfizer
View Trial →
NCT06270316 Phase 1, Phase 2
Recruiting
Safety, PK/PD, and Exploratory Efficacy Study of AMT-191 in Classic Fabry Diseas...
Condition
Fabry Disease
Enrollment
20 pts
Location
United States
Sponsor
UniQure Biopharma B.V.
View Trial →
NCT03217006 N/A
Recruiting
Randomization of Single vs Multiple Arterial Grafts
Condition
Coronary Artery Disease
Enrollment
4,300 pts
Location
United States, Austria, Brazil
Sponsor
Weill Medical College of Corne
View Trial →
NCT04181138 N/A
Recruiting
Primary Sclerosing Cholangitis in Children
Condition
Primary Sclerosing Cholangitis
Enrollment
1,000 pts
Location
United States, Canada
Sponsor
Arbor Research Collaborative f
View Trial →
NCT07082738 Phase 2
Recruiting
A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Ve...
Condition
Chronic Obstructive Pulmonary Disease (COPD)
Enrollment
987 pts
Location
United States, Argentina, Australia
Sponsor
AstraZeneca
View Trial →
NCT04310241 N/A
Recruiting
Visual Function Abnormalities in Strabismus and Amblyopia and Response to Therap...
Condition
Amblyopia
Enrollment
150 pts
Location
United States
Sponsor
The Cleveland Clinic
View Trial →
NCT06750094 Phase 3
Recruiting
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in P...
Condition
Colorectal Neoplasms
Enrollment
700 pts
Location
United States, Australia, Belgium
Sponsor
Janssen Research & Development
View Trial →
NCT05803941 Phase 4
Recruiting
Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With ...
Condition
Prostate Cancer
Enrollment
700 pts
Location
United States, Austria, Belgium
Sponsor
Novartis Pharmaceuticals
View Trial →
NCT05137054 Phase 1
Recruiting
A Study to Examine the Effects of Novel Therapy Linvoseltamab in Combination Wit...
Condition
Multiple Myeloma
Enrollment
317 pts
Location
United States, France, Greece
Sponsor
Regeneron Pharmaceuticals
View Trial →
NCT07566156 Phase 3
Recruiting
Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradioth...
Condition
Urothelial Cancer
Enrollment
390 pts
Location
United States, Canada, South Korea
Sponsor
Astellas Pharma Global Develop
View Trial →
NCT06649201 N/A
Recruiting
Vulvovaginal Graft-versus-Host Disease: Diagnosis and Microbiome Evaluation
Condition
Graft Vs Host Disease
Enrollment
40 pts
Location
United States
Sponsor
Case Comprehensive Cancer Cent
View Trial →
NCT07917208 N/A
Recruiting
Early Feasibility Study of the Capstan Medical TMVR System
Condition
Mitral Regurgitation (MR)
Enrollment
15 pts
Location
United States
Sponsor
Capstan Medical
View Trial →
NCT05911568 N/A
Recruiting
Treatment With Endovascular Intervention for STroke Patients With Existing Disab...
Condition
Stroke
Enrollment
1,060 pts
Location
United States
Sponsor
University of Cincinnati
View Trial →
Page 7 of 19 — 475 trials total
← Prev Next →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology